The Newborn Project: Examining the Oxygenation of Brain Tissue During General Anesthesia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03057587 |
Recruitment Status :
Withdrawn
(The research never began.)
First Posted : February 20, 2017
Last Update Posted : November 14, 2018
|
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | February 15, 2017 | ||||
First Posted Date | February 20, 2017 | ||||
Last Update Posted Date | November 14, 2018 | ||||
Actual Study Start Date | May 12, 2017 | ||||
Actual Primary Completion Date | April 27, 2018 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Cerebral Oxygenation [ Time Frame: Intraoperative period ] Determine what factors are correlated with changes in the cerebral oxygenation
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | The Newborn Project: Examining the Oxygenation of Brain Tissue During General Anesthesia | ||||
Official Title | The Newborn Project: A Prospective Observational Study Examining the Oxygenation of Brain Tissue During General Anesthesia Using Near Infrared Spectroscopy Technology | ||||
Brief Summary | This study will be an observational, prospective trial that will measure the cerebral oxygenation of infants scheduled to undergo general anesthesia at Boston Children's Hospital. | ||||
Detailed Description | Data will be collected from the Near Infrared Spectroscopy (NIRS) monitor and the patient's medical record. When the NIRS sensor is attached to the patient's forehead the oxygenation of brain tissue will be continuously monitored. All other information will be routinely recorded as standard clinical care and this information will be obtained from the patient's medical record. The NIRS monitor data will by time synched to the anesthesia record and downloaded to a secured password protected file. In the post-operative period, patient data will be collected including: 1) any skin findings related to the placement of the NIRS or pulse oximetry probes 2) any unanticipated need for hemodynamic support, 3) laboratory values including hemoglobin levels, electrolytes, and blood gases, 4) new neurological findings (seizures etc.) |
||||
Study Type | Observational | ||||
Study Design | Observational Model: Case-Only Time Perspective: Prospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Infants scheduled to undergo general anesthesia at Boston Children's Hospital | ||||
Condition | Blood Pressure | ||||
Intervention | Device: NIRS Monitoring
NIRS data will be collected throughout the surgery
|
||||
Study Groups/Cohorts | NIRS Monitoring
A NIRS sensor will be placed on the forehead of the patient upon entry to the operating room and will remain on, as tolerated, for the duration of surgery
Intervention: Device: NIRS Monitoring
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Withdrawn | ||||
Actual Enrollment |
0 | ||||
Original Estimated Enrollment |
200 | ||||
Actual Study Completion Date | April 27, 2018 | ||||
Actual Primary Completion Date | April 27, 2018 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | up to 6 Months (Child) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03057587 | ||||
Other Study ID Numbers | IRB-P00021194 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Responsible Party | Mary Ellen McCann, Boston Children's Hospital | ||||
Study Sponsor | Boston Children's Hospital | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | Boston Children's Hospital | ||||
Verification Date | November 2018 |